Observational study / 2013
Higher urinary phytate levels were correlated with reduced lumbar spine bone loss and lower 10-year fracture probability in postmenopausal women.
A study evaluated 157 postmenopausal women categorized by low (≤0.76 μM), intermediate (0.76-1.42 μM), or high (≥1.42 μM) urinary phytate (InsP6) concentrations, measuring densitometry over 12 months and 10-year fracture risk via FRAX. Women with low InsP6 had significantly greater lumbar spine bone mass loss than those with high levels (3.08 ± 0.65% vs. 0.43 ± 0.55%), with more women in the low group losing over 2% bone mass (55.6% vs. 20.7%). The 10-year fracture probability was also significantly higher in the low-phytate group than the high-phytate group for hip fracture (0.37 ± 0.06% vs. 0.18 ± 0.04%) and major osteoporotic fracture (2.45 ± 0.24% vs. 1.83 ± 0.11%).
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 157 postmenopausal women
- What was measured
- Bone mass loss and 10-year fracture risk (FRAX)
THE PAPER
Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal women.
López-González AA, Grases F, Monroy N, Marí B, Vicente-Herrero MT, Tur F, Perelló J. Eur J Nutr, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.